Helios & Matheson Analytics, Inc. engages in the provision of information technology services and solutions. The company is headquartered in New York City, New York. The firm offers its clients a suite of services of predictive analytics with technology. The firm provides offerings in the areas of application value management, application development, integration, independent validation, infrastructure and information management, and analytics services. The firm offers an integrated service of Big Data technology, analytics, domain knowledge in the areas of financial services and healthcare, including data visualization. The firm's clients operate in a range of industries with a concentration in the banking, financial services, insurance and healthcare industries.
Based on comprehensive analyst evaluations, we have synthesized critical insights from expert assessments to outline a cautious outlook for HMNY. Analysts note deteriorating fundamentals and challenging market sentiment, indicating potential downside risks in the near term. Following this expert analysis, we adopt a bearish stance on this stock. Our conclusion: HMNY is a Sell candidate.
HMNY stock price ended at $0 on 月曜日, after rising NaN%
On the latest trading day Jan 26, 2026, the stock price of HMNY rose by NaN%, climbing from $0.00 to $0.00. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $0.00 and a high of $0.00. Notably, trading volume dropped by 65.1K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 71.9K shares were traded, equating to a market value of approximately --.